Therefore, PARP1 is reportedly overexpressed in multiple cancers including those involving BRCA1/2 mutation, neuroblastoma, ovarian cancer, human papilloma virus-infected oropharyngeal carcinoma, Ewing’s sarcoma, and colon cancer (53, 54). Here, PARP1 is linked to ovarian carcinoma.